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ABSTRACT 
 
Recently, NIH has funded a center for autophagy research named the Autophagy, 
Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence, 
located at the University of New Mexico Health Science Center (UNM HSC), with 
aspirations to promote autophagy research locally, nationally, and internationally. 
The center has 3 major missions: (i) to support junior faculty in their endeavors to 
develop investigations in this area and obtain independent funding; (ii) to develop 
and provide technological platforms to advance  autophagy research with 
emphasis on cellular approaches for high quality reproducible research; and (iii) to 
foster international collaborations through the formation of an International Council 
of Affiliate Members and through hosting national and international workshops and 
symposia. Scientifically, the AIM center is focused on autophagy and its 
intersections with other processes, with emphasis on both fundamental 
discoveries and applied translational research.  
 
 
 
Introduction 
The purpose of this article is to inform the international autophagy research 
community about the establishment of a new center for autophagy research that 
we think will be a useful resource to the scientific community interested in 
fundamental and disease-related research on autophagy. The National Institutes 
of Health (NIH) Centers of Biomedical Research Excellence (CoBRE) program, of 
which the Autophagy, Inflammation, and Metabolism Center (AIM) is a part of and 
is funded by, has the mission to develop research capacity through several 
mechanisms housed within thematic centers focused on a multidisciplinary theme, 
such as autophagy, with cross-cutting implications for both fundamental science 
and translational research. The AIM center’s specific mission is to provide a 
national and international hub for advancement of autophagy research. This 
includes autophagy and its connections with other fundamental processes, often 
in disease contexts but also from the perspective of basic science. The initial and 
evolving processes for achieving these goals are multi-pronged as described 
below.  
 
Enabling junior investigators whose research is focused on autophagy as 
the central theme of the center 
The research-building mechanism that will have the most significance and financial 
impact through the AIM center is to provide multi-year funding support to junior 
faculty. This funding of individual projects is at a level equivalent to a typical NIH 
R01 project, or independent group leader funding, enabling junior 
investigators (usually starting Assistant Professors on a tenure track, referred to 
as mentored Principal Investigators, or “mPIs”) to develop their program 
sufficiently to be able to compete for their own independent R01-level funding. This 
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is done in a mentored and collaborative environment, further bolstered by high-
end shared equipment core facilities, accessible initially without added cost to both 
mPIs and other AIM’s members. The mPIs are appointed for a specifc number of 
years (typically 3), after which they graduate. Upon graduation, former mPIs 
remain tightly associated with the center, maintaining their membership status, and 
transfer their experience to other active and new mPIs in the center. They retain 
the same space, which is usually provided by their home departments at the 
outset. An mPI’s graduation in turn triggers formal searches for new junior 
investigators, who are identified via local and external competitive searches and 
selection processes. Upon their selection, new mPIs are given their funding and 
access to facilities through the center and are integrated into the center’s activities.  
 
Building a broader community of scholars with interests focused on the 
central theme of autophagy research 
In addition to supporting junior investigators, the center provides an intellectual 
thematic hub for investigators at multiple stages of their career. This includes the 
scientific leadership of the center and other more senior investigators who play 
mentoring roles. These scientists are full members of the center along with the 
mPIs. Associate members join the center through the simple process of presenting 
their science in a seminar (physically given on the premises or remotely through 
teleconferencing), providing a brief synopsis (half a page) of their project and 
relatedness to the focal theme(s) of the AIM center, and their biosketch/cv. Upon 
receiving a formal vote by the scientific leadership (AIM’s executive committee), 
associate members are installed and obtain privileges to access scientific cores 
and join ongoing formal collaborative initiatives.  Whereas the use of AIM 
technological platforms housed in scientific cores, such as high-content 
microscopy quantification of autophagy processes, may be most accessible 
locally, fixed and processed samples can be shipped from distant sites thus 
providing global access to the facility.   
 
External Advisory Board 
The AIM center has a national External Advisory Board (EAB), with the present 
members being distinguished US scientists: Dr. Beth Levine, UT Southwestern, 
Dallas, Chairperson of the EAB and a leading autophagy researcher; Dr. Vishva 
Dixit, Vice-President of Genentech and international authority on inflammation, Dr. 
Randal Kaufman, the director of the Degenerative Diseases Program, 
Neuroscience and Aging Center at Sanford Burnham Prebys Medical Discovery 
Institute, La Jolla; and Dr. Philipp Scherer, director of the Touchstone Diabetes 
Center at UT Southwestern, Dallas. The role of the EAB is to provide advice to the 
center director, assess the function of the AIM center annually and participate in 
selection and appointments of new mPIs. The composition of the EAB is designed 
to ensure the fulfillment of the goals and broad scientific impact of the AIM center. 
 
International Council of Affiliate members: global cooperation in autophagy 
research 
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The International Council of Affiliate Members (ICAM) is a key component of AIM, 
reaching out to the broader community of autophagy scholars across the globe. 
The role of ICAM is to participate in AIM activities, to foster international 
collaborations, and to engage in the exchange of ideas and technologies of 
relevance for autophagy research. The ICAM members provide their input through 
tele- and video-conferencing and participate in person in the symposia and 
workshops organized at the AIM center. The ICAM is composed of internationally 
renowned leaders in autophagy research or international authorities in other fields 
of key interest to the AIM center. The members come from nearly all continents 
including Africa, Asia, Australia, Europe, North America; and South America 
(Figure 1). The founding members of the ICAM are:  Eric H. Baehrecke (USA), 
Christian Behrends (Germany), Francesco Cecconi (Italy, Denmark), Patrice 
Codogno (France), Guang-Chao Chen (Taiwan), Zvulun Elazar (Israel), Eeva-Liisa 
Eskelinen (Finland) Bernard Fourie (South Africa), Devrim Gozuacik (Turkey), 
Wanjin Hong (Singapore), Gokhan Hotamisligi (USA), Marja Jäättelä (Denmark), 
Terje Johansen (Norway), Eun-Kyeong Jo (South Korea), Gábor Juhász 
(Hungary), Daniel Klionsky (USA), Nicholas Ktistakis (UK), Adi Kimchi (Israel), 
Guido Kroemer (France, Sweden), Noboru Mizushima (Japan), Christian Münz 
(Switzerland), Kevin Ryan (UK), Fulvio Reggiori (The Netherlands), David 
Rubinsztein (UK), Kate Schroder (Australia), Anne Simonsen (Norway), Sharon 
Tooze (UK), Maria I. Vaccaro (Argentina), Tamotsu Yoshimori (Japan), Li Yu 
(China), and Hong Zhang (China).  It is anticipated that a subset of ICAM members 
will participate in person at the annual AIM meetings and/or workshops. The first 
such event is planned in 2019, in connection with the Keystone Symposium on 
autophagy taking place in Santa Fe, near the AIM center location. It is also 
expected that over time, the productive interactions might grow, at least in some 
cases, into inter-institutional cooperative agreements. 
 
Core facilities 
The AIM center has 3 core facilities: (i) Administrative core; (ii) Autophagy scientific 
core (ASC); and (iii) Inflammation and metabolism core (IMC).  
 
The administrative core is composed of the leadership (Director and executive 
committee) from the ranks of scientists in different departments and schools at the 
UNM HSC. This ensures a broad local base of participants, which is an important 
aspect for the success of the AIM center. The center leadership is assisted by an 
internal advisory board, and by the EAB. The administrative core also provides 
mentoring infrastructure and evaluates progress of junior (mentored) PIs as well 
as the function and contributions of mentoring faculty.  A centerpiece for mentoring 
is an individualized development plan for each mPI, customized to the needs of 
each junior faculty member. The mPIs select a small subset from the list of offered 
core competencies. This list is supplemented by unique, custom developed 
training in consultations with their mentors. This combination allows a high degree 
of personalization to enhance mPIs’ careers and funding success. It is also 
expected that these junior investigators will gain access to broad international 
expertise and collaborations via interactions with the ICAM members. 
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The two technological cores, ASC and IMC, provide instrumentation designed not 
to duplicate but complement the existing conventional facilities, e.g. flow 
cytometry, genomics, confocal microscopy, electron microscopy, animal, and high-
throughput drug screening facilities, etc., available at UNM HSC. The ASC focuses 
on high content microscopy for adherent cells (Cellomics) and for cells in 
suspension (Amnis), to quantitatively analyze in a highly rigorous manner (and 
thus promote reproducibility in research) autophagic profiles as well as other 
subcellular structures and changes.  The IMC focuses on inflammatory (e.g. Amnis 
in its flow cytometry mode) and metabolic measurements (e.g. Seahorse, etc.). 
The AIM center has a development program to update and acquire new 
instruments over time. The instrumentation is covered by service contracts and 
appropriate user charges will be implemented in support of extended service 
contracts in the out years. The cores are supervised by core directors and daily 
operations (user scheduling, user training, and equipment maintenance) are 
carried out by the core technical director with users following clearly defined and 
web-accessible standard operating procedures.  Importantly, the principal model 
for access to core instrumentation by AIM members, associate members, and 
affiliated members is not based on charges during the first several years, but rather 
by establishing a membership user base, with any charges being implemented in 
the out years as described above or for external non-member users from the 
outset.  Because fixed specimens (e.g. cells in 96 well plates), can be shipped, 
AIM is prepared to provide service not just locally but also nationally and 
internationally via collaborative agreements. 
 
Modes of growing the base and promoting autophagy research  
The AIM center has pilot programs and announces Requests for Applications 
(RFA) that are offered at least twice a year. These can be themed or investigator 
initiated, depending on the RFA, but are focused on autophagy and its 
intersections with other areas. The pilots stimulate autophagy research locally. 
Another process is hiring faculty through a national/international search for tenure-
track Assistant Professors. These are usually triggered upon graduation of an mPI, 
when she or he acquires independent R01 or equivalent funding. The 
corresponding funds, in the amount (depending on circumstances) close to an 
R01-level funding, are then transferred to newly appointed mPIs. Mentors and 
mentees are also encouraged to collaborate and publish together, which further 
expands autophagy research to include more senior investigators. Finally, 
international collaborations fostered through ICAM are expected to provide a home 
to and a role for ICAM affiliate members and intend to integrate the AIM center 
within the international community of autophagy scholars. 
 
Events, meetings, symposia and workshops 
The AIM center has bi-weekly Tuesday AIM seminars (TAIMs). TAIMs are 
envisioned to be somewhat different than a conventional seminar series. First, 
formal presentations are 30 min, whereas the second half of an hour-long TAIM’s 
meeting is reserved for informal discussions and mingling. The presentations at 
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TAIMs are a mix of work in progress with raw data, a venue for presentation by 
potential associate members, summary of technical advances and equipment 
capabilities organized by cores’ leadership, journal clubs, and a venue for progress 
presentations given by the mPIs.  
 
Every year, the AIM center plans an annual symposium, where AIM members and 
invited speakers present their work and seminars, whereas trainees present 
posters or give short platform talks. Some of the annual meetings will be formatted 
as workshops and will include both practical and theoretical components and will 
drawing on the pool of speakers from the ICAM and other sources. 
 
Dissemination of information  
Events at, and news from, AIM that are of general interest to the international 
autophagy community are disseminated through the AIM center via its web site 
(https://www.autophagy.center), Twitter (www.twitter.com/AIM_autophagy) and 
Facebook (www.facebook.com/aimautophagy).   Blog capabilities for active 
discussions are under development. 
 
Present and evolving research at the AIM center 
The research programs at the AIM center include mPIs funded projects centered 
on autophagy, but also addressing inflammation or metabolism as well as their 
interconnections. The more senior personnel have a diverse portfolio of research 
funded independently of the AIM center. Through collaborative efforts, it is 
expected that the majority of senior investigators will find synergy with the central 
theme of the center. Once mPIs “graduate” they remain as AIM members, and 
their role as contributors to the AIM center community of scholars is expected to 
remain permanent. Continued participation by former mPIs in AIM research 
activities, collaborations, and events and group activities will ensure continuing 
connection with AIM and support from AIM will depend on maintaining such 
relationships and collegiality.  New recruits at the level of Assistant Professors on 
tenure track will be brought into the system and their work will infuse the AIM center 
with evolving new directions that they will bring with them. This mechanism avoids 
stagnation and should ensure a dynamic research portfolio keeping up with the 
most recent research trends and technologies.  
 
Future of the AIM center 
The AIM center had a grand opening event in March 2018, with Randy Schekman 
delivering the keynote lecture, followed by a reception. Renovations of the floor on 
which AIM is located are underway. Two mPIs have already graduated, i.e. 
obtained their independent R01 grants, and faculty searches for new mPIs are 
underway. As noted above, the AIM symposium planned for 2019 will be 
associated with the autophagy Keystone Symposia meeting in Santa Fe. In other 
years, a subset of ICAM affiliate members will be invited for workshops or 
symposia. In some instances, there will be practical courses and demonstrations 
of new technologies. The AIM center is expected to contribute to the scientific 
progress in the area of autophagy, both fundamental and applied/translational, and 
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enhance output and funding in the areas of autophagy, inflammation, and 
metabolism, through publications and funding, enabling junior investigators to 
achieve significant independent funding, and continuing replenishment of faculty 
ranks. It will strive to become a hub for national and international research in 
autophagy, enabling independent careers of junior faculty in a supportive, inviting 
and cooperative environment for which the international autophagy community has 
always been famous. Given that the mechanism of funding provides options for 3 
phases each of 5 years in duration, the impact of the AIM center on the local, 
national and international scene may provide constant service and an intellectual 
gathering place over the next 15 years.  
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Figure 1. Global distribution of AIM’s International Council of Affiliate members 
(ICAM). Initials, affiliate members; full names are given in the text. 
 
 
